CoreLine Soft Co

CoreLine Soft Co Financial Leverage

The Financial Leverage (Equity Multiplier) of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is 2.24. In the previous year, Financial Leverage (Equity Multiplier) was 6.73 — a change of -66.65% (lower).

Financial Leverage

2.24

YoY

-66.65%

Last updated:

Financial Leverage (Equity Multiplier) of CoreLine Soft Co is 2025 2.24 . Financial Leverage (Equity Multiplier) of CoreLine Soft Co was 2024 6.73 . It decreases by -66.65% lower compared to the previous year.

The CoreLine Soft Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
1.83 KRW
Jan 1, 2021
1.25 KRW
Jan 1, 2022
2.57 KRW
Jan 1, 2023
1.35 KRW
Jan 1, 2024
6.73 KRW
Jan 1, 2025
2.24 KRW
The CoreLine Soft Co Financial Leverage history
YEARFinancial LeverageYoY
2.24-66.65%
6.73+396.94%
1.35-47.39%
2.57+105.74%
1.25-31.47%
1.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

Financial Leverage (Equity Multiplier) of CoreLine Soft Co is 2.24 in 2025.

Financial Leverage (Equity Multiplier) of CoreLine Soft Co changed from 6.73 to 2.24, representing a -66.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s CoreLine Soft Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co